Safety and Effectiveness of MPCD Therapy on the Treatment of Malignant Pleural Effusion
Status:
Unknown status
Trial end date:
2021-06-15
Target enrollment:
Participant gender:
Summary
This is a prospective, open-label , multicenter randomized controlled trial, with 248 cases
in 50 centers planned for a period of 2 years. The aim of the study is to evaluate the safety
and effectiveness of microparticles packaging chemotherapeutic drugs (MPCD) therapy on the
treatment of malignant pleural effusion (MPE) in patients with advanced lung cancer or breast
cancer.